Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €35.98 EUR
Change Today -0.22 / -0.61%
Volume 3.6K
ALGBE On Other Exchanges
EN Paris
As of 11:36 AM 10/6/15 All times are local (Market data is delayed by at least 15 minutes).

global bioenergies sa (ALGBE) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/26/15 - €59.84
52 Week Low
12/29/14 - €25.74
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

global bioenergies sa (ALGBE) Related Businessweek News

No Related Businessweek News Found

global bioenergies sa (ALGBE) Details

Global Bioenergies produces and sells isobutene. It is developing a process to convert renewable resources into hydrocarbons through fermentation. The company’s isobutene products are petrochemical building blocks that could be converted into fuels, plastics, organic glass, and elastomers. Global Bioenergies was founded in 2008 and is based in Evry, France.

64 Employees
Last Reported Date: 06/8/15
Founded in 2008

global bioenergies sa (ALGBE) Top Compensated Officers

Co-Founder, Chief Executive Officer, Chairman...
Total Annual Compensation: €175.0K
Compensation as of Fiscal Year 2014.

global bioenergies sa (ALGBE) Key Developments

Global Bioenergies Names John Pierce as Chairman of its Board of Directors

Global Bioenergies announced that John Pierce has been appointed as the new Chairman of its board of directors. John Pierce is an American veteran in the field of Industrial Biology and was until recently the Chief Bioscientist at BP plc (British Petroleum).

Global Bioenergies Announces Consolidated Earnings Results for the Six Months Ended June 30, 2015

Global Bioenergies announced consolidated earnings results for the six months ended June 30, 2015. For the period, the company reported operating income of EUR 761,000 compared with EUR 3,171,000 for the same period a year ago. Operating loss was EUR 6,040,000 compared with EUR 9,501,000 for the same period a year ago. Net loss was EUR 6,129,000 compared with EUR 7,578,000 for the same period a year ago. Operating cash out flow was EUR 6,090,000 compared with EUR 8,009,000 for the same period a year ago.

Global Bioenergies Presents at World Congress on Industrial Biotechnology, Jul-20-2015 10:30 AM

Global Bioenergies Presents at World Congress on Industrial Biotechnology, Jul-20-2015 10:30 AM. Venue: Palais des congrès de Montréal, Montréal, Quebec, Canada. Speakers: Frédéric Paques, Chief Technology Officer and Member of Coordination Committee.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALGBE:FP €35.98 EUR -0.22

ALGBE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gevo Inc $2.06 USD +0.04
View Industry Companies

Industry Analysis


Industry Average

Valuation ALGBE Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 52.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLOBAL BIOENERGIES SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at